| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/11/2013 | US8459132 Systems and methods for monitoring a solid-liquid interface |
| 06/11/2013 | US8459100 In-situ water analysis method and system |
| 06/11/2013 | CA2556769C Method of homogenisation and, optionally, analysis for processing moist noble metal-containing recycling materials with an unknown noble metal content |
| 06/11/2013 | CA2533542C Method of determining sperm capacitation |
| 06/11/2013 | CA2533512C Antagonists and agonists of ldcam and methods of use |
| 06/11/2013 | CA2528108C Lateral flow strip and method with conjugate flow subsequent to sample flow |
| 06/11/2013 | CA2523479C Method for determination of the formation factor for a subterranean deposit from measurements on drilling waste removed therefrom |
| 06/11/2013 | CA2520936C An antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same |
| 06/11/2013 | CA2498004C Compositions and methods for the diagnosis and treatment of tumor |
| 06/11/2013 | CA2497555C Detection of biological molecules by differential partitioning of enzyme substrates and products |
| 06/11/2013 | CA2481349C Peptides for detection of antibody to a. phagocytophilum |
| 06/11/2013 | CA2467859C Ionisation devices |
| 06/11/2013 | CA2451002C Cytochrome p-450 gene cluster from rhodococcus ruber and uses thereof in ether fuel cleavage |
| 06/11/2013 | CA2448835C Use of follistatin to increase muscle mass |
| 06/11/2013 | CA2448584C Integrated sample testing meter |
| 06/11/2013 | CA2444407C System for cellular storage and genetic information retrieval |
| 06/11/2013 | CA2442839C Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 06/11/2013 | CA2437453C Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 06/11/2013 | CA2436158C Heavy oil extraction test chamber with configurable temperature profile and feedback control |
| 06/11/2013 | CA2407959C Human wingless-like gene |
| 06/11/2013 | CA2407603C Porphyromonas gingivalis recombinant proteins and truncations |
| 06/11/2013 | CA2406839C G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 06/11/2013 | CA2405473C Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
| 06/11/2013 | CA2404313C Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
| 06/11/2013 | CA2267664C Human telomerase reverse transcriptase |
| 06/06/2013 | WO2013082600A1 Biosensor systems and related methods for detecting analytes in aqueous and biological environments |
| 06/06/2013 | WO2013082463A2 Assays, antibodies, immunogens and compositions related to 5-fu |
| 06/06/2013 | WO2013082375A1 Melittin peptide conjugates and methods employing same |
| 06/06/2013 | WO2013082366A1 Anti-ceacam1 recombinant antibodies for cancer therapy |
| 06/06/2013 | WO2013082307A1 Methods for measuring concentrations of biomolecules |
| 06/06/2013 | WO2013082301A1 Device with integrated allergy testing |
| 06/06/2013 | WO2013082288A1 Glucorticoid receptor gene nr3c1 methylation in irritable bowel syndrome and other stress disorders |
| 06/06/2013 | WO2013082249A2 Compositions and methods for prostate cancer analysis |
| 06/06/2013 | WO2013082248A1 Laser based system for bitumen content determination, e.g., using discrete wavelength spectroscopic analysis |
| 06/06/2013 | WO2013082163A1 A ctc biomarker assay to combat breast cancer brain metastasis |
| 06/06/2013 | WO2013082114A1 Use of p3 of bacteriophage as amyloid binding agents |
| 06/06/2013 | WO2013082105A1 Stat3 activation as a marker for classification and prognosis of dlbcl patients |
| 06/06/2013 | WO2013082043A1 Rbp1 as a molecular biomarker for predicting survival and response to treatment in glioma |
| 06/06/2013 | WO2013082029A1 Compositions and methods for leukocyte differential counting |
| 06/06/2013 | WO2013081987A1 High throughput single nucleotide polymorphism assay |
| 06/06/2013 | WO2013081946A1 Plaque array method and compositions for forming and detecting plaques |
| 06/06/2013 | WO2013081933A1 Point of care immunization testing system |
| 06/06/2013 | WO2013081907A1 Kit for real time liquid measurement and quality control |
| 06/06/2013 | WO2013081903A1 System for producing liquid composition |
| 06/06/2013 | WO2013081812A1 Real time measurement and quality control process for producing liquid composition |
| 06/06/2013 | WO2013081735A1 Metabolism of sod1 in csf |
| 06/06/2013 | WO2013081721A1 Biomarkers for lymphoma |
| 06/06/2013 | WO2013081571A2 Isolated lyssavirus nucleic acid and protein sequences |
| 06/06/2013 | WO2013081496A1 Apparatus and method for determining the toxicity of liquid media |
| 06/06/2013 | WO2013081461A2 Methods and kits for determining protein-bound biomarkers |
| 06/06/2013 | WO2013081363A1 Biosensor for measuring glycosylated haemoglobin using potentiometry |
| 06/06/2013 | WO2013081143A1 Drug containing carrier into cell for forming immune complex |
| 06/06/2013 | WO2013081037A1 IgA-BINDING PEPTIDE AND PURIFICATION OF IgA THEREBY |
| 06/06/2013 | WO2013081036A1 Marker molecule |
| 06/06/2013 | WO2013081035A1 Motor protein device |
| 06/06/2013 | WO2013080937A1 Non-specific reaction inhibition method for continuous immunoassay of substance to be measured in specimen |
| 06/06/2013 | WO2013080917A1 Objective evaluation method for schizophrenia |
| 06/06/2013 | WO2013080811A1 Biomarker for lymphocytic infundibuloneurohypophysitis, and use applications thereof |
| 06/06/2013 | WO2013080606A1 Inspection method for metallic purified lump, manufacturing method for high-purity metal including same, and uses for same |
| 06/06/2013 | WO2013080491A1 Biosensing method in which functional substance-containing microparticles are used |
| 06/06/2013 | WO2013080400A1 Smyd2 as a target gene for cancer therapy and diagnosis |
| 06/06/2013 | WO2013080200A1 A system and method for calculating a composition to be loaded in each well of a protein assay |
| 06/06/2013 | WO2013080198A1 Method for quick assessment of osmolarity |
| 06/06/2013 | WO2013080196A1 Dry eye diagnostic |
| 06/06/2013 | WO2013080184A1 Chimeric protein comprising proinsulin fused to thioredoxin |
| 06/06/2013 | WO2013080050A2 Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor |
| 06/06/2013 | WO2013079981A2 Biomarker-based methods and biochips for aiding the diagnosis of stroke |
| 06/06/2013 | WO2013079977A1 Hand-held test meter with analytical test strip ejection mechanism |
| 06/06/2013 | WO2013079801A1 Method and device for monitoring and controlling the state of a process stream |
| 06/06/2013 | WO2013079764A1 Portable device for measuring blood samples |
| 06/06/2013 | WO2013079755A1 Method and device for the ongoing prediction of the presence of trihalomethanes in supply systems |
| 06/06/2013 | WO2013079670A1 Haploid cells |
| 06/06/2013 | WO2013079606A1 Automated dual stain of mirna and protein targets |
| 06/06/2013 | WO2013079594A1 Device and methods to diagnose pancreatic cancer |
| 06/06/2013 | WO2013079567A2 Nt-proanp and nt-probnp for the diagnosis of stroke |
| 06/06/2013 | WO2013079558A1 Isotopic labeling of higher organisms |
| 06/06/2013 | WO2013079534A2 Method for operating a gas concentration monitoring system, gas measuring device, central unit, gas concentration monitoring system, and computer program product |
| 06/06/2013 | WO2013079532A1 Gas application device for gas measuring apparatuses, method for testing gas measuring apparatus, and calibration measuring apparatus for testing and calibrating gas measuring apparatuses |
| 06/06/2013 | WO2013079487A1 Pharmaceutical composition for use in the treatment of dysfunction associated with aging |
| 06/06/2013 | WO2013079456A1 Clonable tag for correlative light and electron microscopy labeling |
| 06/06/2013 | WO2013079215A1 Method for classifying tumour cells |
| 06/06/2013 | WO2013079177A1 Insert component for storage container for biosensor test elements |
| 06/06/2013 | WO2013079086A1 Environment observation system |
| 06/06/2013 | WO2013079052A1 Plasma polymer membrane |
| 06/06/2013 | WO2013078767A1 Method for measuring glycosyl in a protein |
| 06/06/2013 | WO2013078650A1 Antigen retrieval liquid and antigen retrieval method |
| 06/06/2013 | WO2013078537A1 Paclitaxel response markers for cancer |
| 06/06/2013 | WO2013078515A1 A method and apparatus for sorting and upgrading mined material |
| 06/06/2013 | WO2013070807A8 Niche targeting of quiescent cancer stem cells |
| 06/06/2013 | WO2013056178A3 Novel estrogen receptor mutations and uses thereof |
| 06/06/2013 | WO2013053919A3 Biomarkers of renal disorders |
| 06/06/2013 | WO2013050453A4 Oxmif as a diagnostic marker |
| 06/06/2013 | WO2013050383A3 In vitro method to determine the risk of a pregnant woman of carrying a fetus with fetal aneuploidy |
| 06/06/2013 | WO2013049596A3 Rapid, specific and sensitive immunoassays for the detection of highly variable gram negative bacterial antigens |
| 06/06/2013 | WO2013044187A3 Detecting ovarian cancer |
| 06/06/2013 | WO2013036754A3 Methods and compositions for diagnosis of ovarian cancer |
| 06/06/2013 | WO2013032942A9 Influenza viruses with mutant pb2 gene segment as live attenuated vaccines |
| 06/06/2013 | WO2013030645A8 Dye entrapped sol-gel film based test strip sensor for nitrite and a process of preparing said strip sensor |
| 06/06/2013 | WO2013029609A3 Carrier material for electrically polarisable biomaterials, polyelectrolyte materials, atoms, ions and molecules; production and use thereof |
| 06/06/2013 | WO2013024100A3 Methods for diagnosing and treating medical conditions associated with oxidative stress |